Under the collaboration between Trakcel and Lonza, both the parties have successfully combined Trakcel’s cell orchestration platform Ocellos and Lonza’s manufacturing Moda-Es(R) platform. This means that critical manufacturing steps, checks and data will flow directly into the Chain of Custody and Chain of Identity within the cell and gene therapy supply chain.

Located in Hanau, Germany, Evonik’s new GMP facility will produce pharmaceutical lipids for advanced and pharmaceutical drug delivery applications. It will also offer lipids for clinical and small-scale commercial manufacturing.

The ‘Lab-on-a-chip’ technology means to carry out a single or multiple laboratory function on a single chip. This technology has been adopted by many players in the pharmaceuticals and life sciences industry. LAB Worldwide goes one step further to discuss another revolutionary technology i.e. the organ-on-a-chip technology along with its multiple advantages for the drug discovery and development process.

With an aim to meet the growing demand for high quality cell culture media solutions, Fujifilm has plans to develop a new cell culture media manufacturing facility in Research Triangle Park, North Carolina, USA. The new facility will be operated by Fujifilm Irvine Scientific, a subsidiary of Fujifilm Corporation.

Thermo Fisher Scientific’s new bioanalytical lab is located in Richmond, Virginia and will help to accelerate the firm’s drug discovery process and expand its clinical research operations in the region.

Laboratories across the globe are making use of smart technologies such as Artificial Intelligence (AI)—in line with the ‘Industry 4.0’ concept—due to its numerous advantages as well as to keep up with today’s changing and demanding market requirements. One of the most crucial aspects of the AI technology for laboratories is its ability to analyze large sets of data and also recommend the best possible solutions for developing innovative and at times revolutionary products.

Stäubli Robotics will be launching its new series of robots – Stericlean+ at an upcoming pharma event in 2022. The robots are designed exclusively for use in isolators and deliver high flexibility and precision.

Scientists from ETH Zurich’s Macromolecular Engineering and Organic Chemistry Labs and entrepreneurs from Colorado-based Nanoly Bioscience worked together to develop a safe, versatile platform to increase the thermal stability of vaccines. Their aim? To vastly improve the distribution of viable vaccines and reduce the economic costs of the cold chain.

Researchers from the Telomere-to-Telomere consortium have generated the first complete, gapless sequence of a human genome. The experts believe that this study is vital for understanding the full spectrum of human genomic variation and for examining the genetic contributions to certain diseases.

Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson's disease have a clear genetic signature of the disease in their memory T cells. The scientists hope that targeting these genes may open the door to new Parkinson's treatments and diagnostics.